Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

NCT05088798 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hyperinsulinism

Interventions

DRUG: 18F-Fluoro Dopa PET/MRI Imaging

Sponsor

Washington University School of Medicine

Collaborators

[object Object]